Cerenion Oy is a company set out to bring brain monitoring into intensive care. We believe that, with great innovations and teamwork, we can really change healthcare for the better. Our passion is to help patients as well as doctors and nurses in their challenging work.
We are now looking for a professional with clinical or medical device experience from intensive care to advance the adoption of our technology in clinical use. You are a person who is energized by the idea of working in an up-and-coming company where you get to shape the future of healthcare. The next-generation brain monitoring technology developed by Cerenion provides you with an exciting product to work with.
Your job will be to work with intensive care professionals helping them to improve the care of their patients with our new brain monitoring technology. Training, advising, and collecting user experience will be part of your daily work. You will also support our partner companies when they are ramping up our business in their territories.
Desirable skills and experience:
Clinical experience in intensive care OR experience in intensive care medical devices.
Enthusiasm and social skills for outstanding customer experience.
Fluency in Finnish and English (both spoken and written).
Seen as a benefit:
Understanding of the sales and procurement process in the hospitals.
Experience in working with distributors.
An appreciation of Quality Management. Experience working with ISO 13485 quality management is considered a plus.
What we offer:
The opportunity to help medical professionals to improve the care of their patients.
A position in a highly motivated team and a rising company.
A chance to affect your working environment and career path.
A choice between two locations: Oulu and Helsinki. Other locations may also be considered.
Please, apply to the position by Jan 17, 2021. The applications can be directed to Dr. Timo Koskela, CFO and Head of HR, e-mail
About Cerenion C-Trend® Cerenion Oy has just launched the world’s ﬁrst practical method, C-Trend®, for measuring the brain function of intensive care patients. Cerenion C-Trend® -powered EEG devices provide a new level of ease and confidence in monitoring the neurophysiological status of patients. Based on Artificial Intelligence (AI), the C-Trend® software processes the complex EEG recording to produce a set of easy parameters to aid medical professionals in clinical decision making.
The indications for use of C-Trend® include monitoring of brain function in comatose cardiac arrest survivors as well as detecting epileptic seizure activity and brain hypoxia.
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
Cerenion Oy Elektroniikkatie 3 90590 Oulu FINLAND
Cerenion Oy Firdonkatu 2 T 63 00520 Helsinki FINLAND